CARAWAY therapeutics

Caraway Therapeutics is developing small molecules that activate neurons’ clearance and recycling processes – accelerating removal of toxic materials and defective cellular components. Caraway’s targeted approach combines genetic data and biological understanding to discover small molecules that activate neurons’ clean-up and recycling processes thereby accelerating clearance of toxic materials and defective cellular components.

The word Caraway is a creative play on the company’s cutting-edge approach of “carrying away” accumulations of toxic materials that impair clearance pathways and are associated with the cause of multiple neurodegenerative diseases.

Named while employed at Fassino/Design.

Back to Naming